DMIIR
Drugs Made In America Acquisition II Corp.
NASDAQ · Financial Services · Asset Management · US
$0.05
−8.36%Price chart
Sep 30Oct 7Oct 12Oct 15Oct 21Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$0.06
From 52W high−68.50%
Volume6.00
Market cap$3.30M
P/E (TTM)0.2x
P/S (TTM)—
Div yield—
Key dataNov 4, 2026
Open
$0.06
From 52W high
−68.50%
Volume
6.00
Market cap
$3.30M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−2.5x
P/E (TTM)
0.2x
RSI (14)
42.4
MomentumView details →
1D Return
−8.36%
YTD Return
−60.71%
Similar companies
Latest newsMore news →
No recent news for DMIIR.